Furthermore, STAT1-/- mammary tumor cells are transplantable orthotopically into both immunocompetent and immunodeficient mice, facilitating the examination of immune-based therapies, which otherwise would not be possible in xenograft models using ERα+/PR+ human breast cancer cell lines. This evidence concerns the gene STAT1 and breast cancer.